MediLink Therapeutics
PrivateLast Round
Series B
Mar 14, 2022
Total Funding Raised
$120M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
MediLink Therapeutics is a biopharmaceutical company that develops innovative antibody-drug conjugates (ADC) for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MediLink Therapeutics Comparables
Compare MediLink Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Duality Biotherapeutics Inc | 93% | |
| Aimed Bio Inc. | 82% | |
| LigaChem Biosciences | 79% | |
MediLink Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 14, 2022 | ||||
| Series A | Mar 1, 2021 |
Key People
Founding team and executive leadership
MediLink Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series B |
| Loyal Valley Capital | Series B, Series A |
| Highlight Capital | Series B |
| LYFE Capital | Series B |
| Legend Capital | Series B |
| Qiming Venture Partners | Series B, Series A |
| Panacea Venture Healthcare | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 76% MoM.
- Jul 1, 2025
Dr. Weichang Zhou appointed as new CTO.
MediLink Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MediLink Therapeutics's valuation, stock price, and market status.